Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Nov 2, 2022
- Accession no.
- 0000899243-22-034759
- Filed
- Nov 2, 2022
- Trade date
- Oct 31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $2.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2022 | Common Stock | SSaleDisposed | −7,567 | $44.92F2 | −$339,909.64 | 1,080,953 | Direct | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −7,768 | $46.19F3 | −$358,803.92 | 1,073,185 | Direct | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −11,756 | $46.88F4 | −$551,121.28 | 1,061,429 | Direct | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −2,909 | $47.89F5 | −$139,312.01 | 1,058,520 | Direct | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −5,008 | $44.93F6 | −$225,009.44 | 117,992 | Indirect | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −4,569 | $46.19F7 | −$211,042.11 | 113,423 | Indirect | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −8,235 | $46.91F8 | −$386,303.85 | 105,188 | Indirect | |
| Oct 31, 2022 | Common Stock | SSaleDisposed | −2,188 | $47.91F9 | −$104,827.08 | 103,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.52, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.68 to $48.17, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.555, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.57 to $48.40, inclusive.
Referenced by the price of 1 transaction in Table I.